Urine Biomarker for Kidney Transplant Rejection
An Adaptive Sample Collection to Evaluate a Biomarker for Kidney Transplant Rejection
Sponsor: Exosome Diagnostics, Inc.
Listed as NCT05072951, this observational or N/A phase trial focuses on Graft Rejection and remains ongoing. Sponsored by Exosome Diagnostics, Inc., it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Dec 2025 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Dec 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Dec 2021 — Jul 2024 [monthly]
Not Yet Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting
First recorded
Oct 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Exosome Diagnostics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.